ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE

ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE was reported 1352 times

ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HYPOXANTHINE-GUANINE PHOSPHORIBOSYL TRANSFERASE DEFICIENCY 1 0.3333
1 ELEPHANTIASIS NOSTRAS VERRUCOSA 1 0.1250
2 ANTI-HLA ANTIBODY TEST POSITIVE 1 0.0588
3 HEPATITIS SYPHILITIC 1 0.0556
4 HUMAN T-CELL LYMPHOTROPIC VIRUS INFECTION 1 0.0417
5 VULVOVAGINAL BURNING SENSATION 242 0.0396
6 CHEMICAL BURN OF GENITALIA 4 0.0328
7 CONJUNCTIVOCHALASIS 1 0.0323
8 INSTILLATION SITE HAEMORRHAGE 1 0.0256
9 BEREAVEMENT 1 0.0217
10 MIXED HYPERLIPIDAEMIA 1 0.0192
11 FUNGAL RHINITIS 2 0.0187
12 VULVOVAGINAL PAIN 79 0.0164
13 ENDOSCOPY UPPER GASTROINTESTINAL TRACT ABNORMAL 1 0.0149
14 VULVOVAGINAL PRURITUS 73 0.0144
15 DISRUPTIVE MOOD DYSREGULATION DISORDER 1 0.0135
16 KAWASAKI'S DISEASE 1 0.0132
17 AORTIC VALVE DISEASE MIXED 1 0.0123
18 PERIPHERAL NERVE LESION 4 0.0121
19 ACUTE MONOCYTIC LEUKAEMIA 2 0.0110
20 VULVOVAGINAL DISCOMFORT 47 0.0106
21 LOBULAR BREAST CARCINOMA IN SITU 1 0.0105
22 ELECTROCONVULSIVE THERAPY 1 0.0092
23 ALLERGY TO IMMUNOGLOBULIN THERAPY 1 0.0092
24 CATHETER THROMBOSIS 1 0.0089
25 VAGINAL MUCOSAL BLISTERING 2 0.0089
26 MELANOSIS COLI 1 0.0086
27 TINEA VERSICOLOUR 3 0.0083
28 MESOTHELIOMA MALIGNANT 3 0.0081
29 BURKHOLDERIA TEST POSITIVE 1 0.0081
30 CAR T-CELL-RELATED ENCEPHALOPATHY SYNDROME 1 0.0081
31 INTENTIONAL PRODUCT MISUSE TO CHILD 1 0.0078
32 PAROTID GLAND ENLARGEMENT 5 0.0077
33 INTRAUTERINE INFECTION 1 0.0074
34 VULVOVAGINAL ERYTHEMA 6 0.0072
35 NEURAL TUBE DEFECT 5 0.0069
36 CLEFT LIP 6 0.0069
37 VULVOVAGINAL RASH 3 0.0068
38 VULVOVAGINAL SWELLING 12 0.0066
39 LIPOSUCTION 1 0.0065
40 KIDNEY CONGESTION 1 0.0065
41 CALCULUS URETHRAL 1 0.0065
42 CREATININE URINE DECREASED 1 0.0063
43 CONFUSIONAL AROUSAL 1 0.0062
44 HAND-EYE COORDINATION IMPAIRED 1 0.0059
45 INTESTINAL HAEMATOMA 1 0.0057
46 JEJUNOSTOMY 1 0.0055
47 VULVOVAGINAL INJURY 3 0.0053
48 APPLICATION SITE INJURY 1 0.0053
49 EPIDURAL INJECTION 1 0.0051
50 GASTROSTOMY TUBE SITE COMPLICATION 1 0.0050
51 MERALGIA PARAESTHETICA 1 0.0047
52 DEAFNESS TRANSITORY 4 0.0047
53 CYTOMEGALOVIRUS TEST POSITIVE 8 0.0045
54 INFUSION SITE PHLEBITIS 1 0.0044
55 VULVOVAGINAL INFLAMMATION 2 0.0043
56 FALSE NEGATIVE INVESTIGATION RESULT 3 0.0043
57 CORNEAL NEOVASCULARISATION 1 0.0040
58 TINEA CRURIS 2 0.0040
59 HYDRONEPHROSIS 30 0.0040
60 SUPRAPUBIC PAIN 2 0.0039
61 ANAL ATRESIA 2 0.0037
62 STOMA SITE IRRITATION 2 0.0037
63 MORAXELLA INFECTION 1 0.0036
64 COLON CANCER RECURRENT 1 0.0036
65 GENITAL BLISTER 1 0.0036
66 GENITAL PARAESTHESIA 1 0.0034
67 FALLOPIAN TUBE DISORDER 1 0.0034
68 AURICULAR SWELLING 2 0.0033
69 ALLERGY TO VACCINE 1 0.0032
70 CENTRAL SEROUS CHORIORETINOPATHY 2 0.0029
71 CONJUNCTIVITIS BACTERIAL 1 0.0029
72 TONGUE BITING 6 0.0029
73 GENITAL SWELLING 2 0.0029
74 THERAPEUTIC PROCEDURE 4 0.0029
75 MENTAL RETARDATION 1 0.0028
76 CYTOMEGALOVIRUS ENTERITIS 1 0.0028
77 VIRAL HAEMORRHAGIC CYSTITIS 2 0.0028
78 CRYPTORCHISM 3 0.0027
79 CERVICAL POLYP 1 0.0026
80 HYDROURETER 1 0.0026
81 IMPAIRED REASONING 1 0.0026
82 BACTERIAL VAGINOSIS 4 0.0026
83 HUMAN PAPILLOMA VIRUS TEST POSITIVE 1 0.0025
84 CHEMICAL INJURY 2 0.0024
85 FOETAL DISORDER 2 0.0024
86 CORNEAL DYSTROPHY 1 0.0024
87 CONGENITAL CARDIOVASCULAR ANOMALY 2 0.0024
88 ONYCHOMADESIS 10 0.0024
89 MESOTHELIOMA 3 0.0023
90 GENITAL BURNING SENSATION 2 0.0023
91 MOUTH BREATHING 1 0.0023
92 DIVORCED 1 0.0023
93 ANAEMIA MEGALOBLASTIC 1 0.0022
94 GASTRIC FISTULA 1 0.0022
95 FEEDING INTOLERANCE 1 0.0022
96 MATERNAL DRUGS AFFECTING FOETUS 17 0.0022
97 CIRRHOSIS ALCOHOLIC 1 0.0022
98 VAGINAL DISCHARGE 22 0.0022
99 ANAPHYLACTOID SHOCK 1 0.0021
100 HYPERMETROPIA 2 0.0021
101 GASTROSCHISIS 1 0.0021
102 APLASIA 4 0.0020
103 ABORTION THREATENED 1 0.0020
104 KAPOSI'S SARCOMA 1 0.0020
105 EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) 1 0.0020
106 GLARE 1 0.0019
107 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0019
108 MARITAL PROBLEM 1 0.0019
109 BURSITIS INFECTIVE 1 0.0018
110 INTERTRIGO 1 0.0018
111 MACULE 5 0.0018
112 BODY TINEA 1 0.0018
113 EXPOSURE TO CHEMICAL POLLUTION 3 0.0018
114 BACTERIURIA 1 0.0018
115 CHEMICAL BURN 2 0.0017
116 CORNEAL EPITHELIUM DEFECT 1 0.0017
117 CAMPYLOBACTER GASTROENTERITIS 1 0.0017
118 AORTIC VALVE STENOSIS 3 0.0017
119 APPLICATION SITE DISCOMFORT 3 0.0017
120 FEBRILE CONVULSION 2 0.0016
121 INCORRECT DRUG DOSAGE FORM ADMINISTERED 1 0.0016
122 STOMA SITE ERYTHEMA 3 0.0016
123 BACILLUS INFECTION 1 0.0016
124 CANCER PAIN 4 0.0016
125 ENTEROCOCCUS TEST POSITIVE 1 0.0015
126 COMPULSIONS 1 0.0015
127 COMPLICATIONS OF MATERNAL EXPOSURE TO THERAPEUTIC DRUGS 1 0.0015
128 ANGULAR CHEILITIS 1 0.0014
129 INTERNATIONAL NORMALISED RATIO INCREASED 41 0.0014
130 DERMATITIS DIAPER 1 0.0014
131 CONGENITAL HYDRONEPHROSIS 1 0.0014
132 CYTOMEGALOVIRUS INFECTION 23 0.0014
133 ACCOMMODATION DISORDER 1 0.0014
134 BLUNTED AFFECT 1 0.0014
135 GENITAL PAIN 2 0.0014
136 HEART SOUNDS ABNORMAL 1 0.0013
137 SECONDARY ADRENOCORTICAL INSUFFICIENCY 2 0.0013
138 ENTEROVESICAL FISTULA 1 0.0013
139 ELECTROCARDIOGRAM PR PROLONGATION 1 0.0013
140 CYTOMEGALOVIRUS ENTEROCOLITIS 1 0.0013
141 BREAST FEEDING 1 0.0013
142 ELECTROCARDIOGRAM QT CORRECTED INTERVAL PROLONGED 1 0.0013
143 FUNGAEMIA 2 0.0013
144 VULVOVAGINAL MYCOTIC INFECTION 5 0.0013
145 BREAST CALCIFICATIONS 1 0.0013
146 ENDOMETRIAL HYPERPLASIA 1 0.0012
147 BREAST OPERATION 1 0.0012
148 GRANULOMA SKIN 1 0.0012
149 BALANOPOSTHITIS 1 0.0012
150 PATHOLOGICAL GAMBLING 2 0.0012
151 ODYNOPHAGIA 7 0.0012
152 CRANIOSYNOSTOSIS 1 0.0012
153 DERMATITIS ACNEIFORM 7 0.0011
154 PARTIAL SEIZURES 6 0.0011
155 INFUSION SITE DISCOLOURATION 1 0.0011
156 ANOGENITAL WARTS 1 0.0011
157 CATHETER MANAGEMENT 1 0.0011
158 INTESTINAL INFARCTION 1 0.0011
159 STOMA SITE DISCHARGE 3 0.0011
160 CERUMEN IMPACTION 1 0.0011
161 LOBAR PNEUMONIA 2 0.0011
162 HYPERACUSIS 4 0.0011
163 RENAL TUBULAR DISORDER 3 0.0011
164 MICROANGIOPATHY 1 0.0011
165 BLADDER CATHETERISATION 1 0.0010
166 CROSS SENSITIVITY REACTION 1 0.0010
167 LYMPHADENECTOMY 1 0.0010
168 BONE MARROW DEPRESSION 1 0.0010
169 HAEMOPHILUS INFECTION 1 0.0010
170 PYELONEPHRITIS ACUTE 2 0.0010
171 COLON ADENOMA 1 0.0010
172 OESOPHAGEAL CANDIDIASIS 4 0.0010
173 ERYSIPELAS 5 0.0010
174 BRAIN STEM INFARCTION 1 0.0010
175 ANAPHYLACTOID REACTION 4 0.0010
176 CAROTID ARTERIOSCLEROSIS 1 0.0010
177 VAGINAL HAEMORRHAGE 42 0.0010
178 INFUSION SITE DISCOMFORT 1 0.0010
179 HYPOSPADIAS 2 0.0010
180 FEEDING DISORDER NEONATAL 1 0.0010
181 GALLBLADDER ENLARGEMENT 1 0.0009
182 INFUSION SITE MASS 1 0.0009
183 DRUG EXPOSURE VIA BREAST MILK 1 0.0009
184 BLOOD TESTOSTERONE ABNORMAL 1 0.0009
185 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 1 0.0009
186 CARDIAC HYPERTROPHY 1 0.0009
187 FACIAL PAIN 8 0.0009
188 LYMPHOCYTE COUNT ABNORMAL 1 0.0009
189 EYE MOVEMENT DISORDER 6 0.0009
190 GASTROINTESTINAL BACTERIAL INFECTION 1 0.0009
191 ADMINISTRATION SITE PAIN 1 0.0009
192 APPLICATION SITE PAIN 19 0.0009
193 RALES 5 0.0009
194 SPINAL COLUMN STENOSIS 4 0.0008
195 INGROWING NAIL 2 0.0008
196 HAEMORRHAGE SUBCUTANEOUS 3 0.0008
197 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 1 0.0008
198 DYSFUNCTIONAL UTERINE BLEEDING 1 0.0008
199 RETROPERITONEAL HAEMORRHAGE 2 0.0008
200 FREEZING PHENOMENON 3 0.0008
201 INJECTION SITE ABSCESS 2 0.0008
202 ALLERGY TO CHEMICALS 1 0.0008
203 INTRADUCTAL PROLIFERATIVE BREAST LESION 1 0.0008
204 LIP DISCOLOURATION 1 0.0008
205 EXCORIATION 2 0.0008
206 RESPIRATORY RATE INCREASED 7 0.0008
207 BRONCHIAL SECRETION RETENTION 1 0.0008
208 LEFT ATRIAL DILATATION 1 0.0008
209 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 1 0.0008
210 MICROCEPHALY 1 0.0008
211 LIP DRY 7 0.0008
212 ADJUSTMENT DISORDER 1 0.0008
213 COUNTERFEIT PRODUCT ADMINISTERED 1 0.0008
214 GASTROENTERITIS NOROVIRUS 1 0.0008
215 CORNEAL OPACITY 1 0.0007
216 BLOOD PHOSPHORUS INCREASED 2 0.0007
217 APPLICATION SITE HAEMORRHAGE 2 0.0007
218 SUBDURAL HAEMORRHAGE 2 0.0007
219 INFUSION SITE RASH 1 0.0007
220 CULTURE URINE POSITIVE 1 0.0007
221 ANTIPSYCHOTIC DRUG LEVEL INCREASED 2 0.0007
222 GLOMERULAR FILTRATION RATE ABNORMAL 1 0.0007
223 GENITAL RASH 1 0.0007
224 SALIVARY HYPERSECRETION 7 0.0007
225 INVESTIGATION ABNORMAL 1 0.0007
226 CARDIAC MURMUR 6 0.0007
227 TOOTH ABSCESS 7 0.0007
228 SPINAL OSTEOARTHRITIS 6 0.0007
229 GENERALISED ANXIETY DISORDER 1 0.0007
230 GROWTH RETARDATION 2 0.0007
231 APRAXIA 1 0.0007
232 INTERCEPTED DRUG DISPENSING ERROR 1 0.0007
233 INFERTILITY 1 0.0007
234 EPICONDYLITIS 1 0.0007
235 GENITAL HERPES 1 0.0007
236 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
237 CUSHINGOID 2 0.0006
238 BLOOD CALCIUM DECREASED 7 0.0006
239 DISINHIBITION 1 0.0006
240 SKIN EROSION 2 0.0006
241 DENTAL IMPLANTATION 1 0.0006
242 TOOTH INFECTION 8 0.0006
243 EXPIRED DRUG ADMINISTERED 3 0.0006
244 NEAR DEATH EXPERIENCE 2 0.0006
245 ORGANISING PNEUMONIA 3 0.0006
246 ILLUSION 1 0.0006
247 SKIN INJURY 2 0.0006
248 HEPATORENAL SYNDROME 1 0.0006
249 AMMONIA INCREASED 3 0.0006
250 ECCHYMOSIS 4 0.0006
251 MILIARIA 1 0.0006
252 APLASIA PURE RED CELL 2 0.0006
253 ORAL DISCOMFORT 8 0.0006
254 MENINGITIS CRYPTOCOCCAL 1 0.0006
255 PRODUCT CONTAMINATION 2 0.0006
256 BLOOD CREATININE INCREASED 36 0.0006
257 BODY TEMPERATURE ABNORMAL 1 0.0005
258 BLINDNESS TRANSIENT 4 0.0005
259 ON AND OFF PHENOMENON 3 0.0005
260 FEELING DRUNK 4 0.0005
261 BLADDER SPASM 1 0.0005
262 IMPULSIVE BEHAVIOUR 2 0.0005
263 HYPOPROTEINAEMIA 1 0.0005
264 FACE INJURY 2 0.0005
265 PRODUCT PACKAGING ISSUE 5 0.0005
266 INTENTIONAL MISUSE 1 0.0005
267 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
268 LYMPHADENOPATHY MEDIASTINAL 1 0.0005
269 SKIN ATROPHY 3 0.0005
270 CUTANEOUS LUPUS ERYTHEMATOSUS 1 0.0005
271 PELVIC FRACTURE 4 0.0005
272 SKIN FISSURES 10 0.0005
273 COLOSTOMY 1 0.0005
274 CANDIDIASIS 2 0.0005
275 OBSESSIVE-COMPULSIVE DISORDER 4 0.0005
276 FUNGAL SKIN INFECTION 2 0.0005
277 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 3 0.0005
278 APPLICATION SITE PRURITUS 11 0.0005
279 ATRIAL THROMBOSIS 1 0.0005
280 TOOTH LOSS 10 0.0005
281 ANAL PRURITUS 1 0.0005
282 ACCIDENTAL EXPOSURE 2 0.0005
283 HEPATIC NEOPLASM MALIGNANT 1 0.0005
284 SKIN HAEMORRHAGE 7 0.0005
285 FEBRILE BONE MARROW APLASIA 2 0.0005
286 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 8 0.0005
287 APPLICATION SITE SCAB 1 0.0005
288 INFUSION SITE BRUISING 1 0.0005
289 INCORRECT PRODUCT ADMINISTRATION DURATION 10 0.0005
290 BIPOLAR I DISORDER 1 0.0005
291 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
292 DEVICE RELATED INFECTION 7 0.0005
293 GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0005
294 ELECTROCARDIOGRAM T WAVE INVERSION 1 0.0005
295 RHINITIS ALLERGIC 2 0.0004
296 BASAL CELL CARCINOMA 7 0.0004
297 SUSPECTED OFF LABEL USE 2 0.0004
298 THERAPEUTIC PRODUCT EFFECT DELAYED 2 0.0004
299 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
300 INFUSION SITE INFECTION 1 0.0004
301 MOUTH ULCERATION 9 0.0004
302 VAGINAL INFECTION 2 0.0004
303 TONGUE DISORDER 3 0.0004
304 CANDIDA INFECTION 7 0.0004
305 LYMPHADENITIS 1 0.0004
306 APPLICATION SITE BURN 2 0.0004
307 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
308 HYPERNATRAEMIA 2 0.0004
309 CATHETER SITE HAEMORRHAGE 1 0.0004
310 BRAIN ABSCESS 1 0.0004
311 CHEMICAL BURN OF SKIN 1 0.0004
312 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 2 0.0004
313 DIABETIC COMPLICATION 1 0.0004
314 PHARYNGEAL OEDEMA 6 0.0004
315 MEAN CELL VOLUME INCREASED 1 0.0004
316 APNOEA 3 0.0004
317 PULMONARY HAEMORRHAGE 3 0.0004
318 AGRANULOCYTOSIS 7 0.0004
319 SEPSIS 42 0.0004
320 ANGIONEUROTIC OEDEMA 1 0.0004
321 HYPERLACTACIDAEMIA 1 0.0004
322 BREAST CANCER METASTATIC 4 0.0004
323 GAMBLING DISORDER 1 0.0004
324 ABDOMINAL RIGIDITY 1 0.0004
325 HYDROCEPHALUS 2 0.0004
326 DRUG INTERACTION 58 0.0004
327 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
328 HEART RATE ABNORMAL 2 0.0004
329 PRODUCT LEAKAGE 2 0.0004
330 ACUTE PULMONARY OEDEMA 2 0.0004
331 PAIN IN JAW 10 0.0004
332 LIP PAIN 1 0.0003
333 HERPES VIRUS INFECTION 2 0.0003
334 FIBULA FRACTURE 1 0.0003
335 ADENOVIRUS INFECTION 1 0.0003
336 LUMBAR SPINAL STENOSIS 1 0.0003
337 URINE ODOUR ABNORMAL 2 0.0003
338 CATARACT OPERATION 2 0.0003
339 MUSCLE RIGIDITY 4 0.0003
340 BLOOD CULTURE POSITIVE 1 0.0003
341 HIV INFECTION 1 0.0003
342 LOSS OF EMPLOYMENT 1 0.0003
343 KERATITIS 1 0.0003
344 FOETAL GROWTH RESTRICTION 2 0.0003
345 DYSCHEZIA 1 0.0003
346 DIABETIC FOOT 1 0.0003
347 UROSEPSIS 3 0.0003
348 DIASTOLIC DYSFUNCTION 1 0.0003
349 ANKLE FRACTURE 5 0.0003
350 BLOOD ALKALINE PHOSPHATASE INCREASED 8 0.0003
351 APPLICATION SITE IRRITATION 4 0.0003
352 INCORRECT DRUG ADMINISTRATION DURATION 9 0.0003
353 INFUSION SITE PRURITUS 1 0.0003
354 GAMMA-GLUTAMYLTRANSFERASE INCREASED 7 0.0003
355 SLEEP APNOEA SYNDROME 6 0.0003
356 BURNING SENSATION 22 0.0003
357 WHITE BLOOD CELL COUNT ABNORMAL 2 0.0003
358 GLOSSODYNIA 7 0.0003
359 CHOLESTASIS 6 0.0003
360 ROTATOR CUFF SYNDROME 4 0.0003
361 LOOSE TOOTH 1 0.0003
362 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0003
363 BACTERIAL SEPSIS 1 0.0003
364 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
365 POLYP 2 0.0003
366 ANHEDONIA 8 0.0003
367 INFUSION SITE HAEMORRHAGE 1 0.0003
368 CYTOLYTIC HEPATITIS 1 0.0003
369 DYSURIA 11 0.0003
370 POST-TRAUMATIC STRESS DISORDER 2 0.0003
371 TOXIC SKIN ERUPTION 3 0.0003
372 B-CELL LYMPHOMA 1 0.0003
373 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
374 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
375 BLOOD CREATININE ABNORMAL 1 0.0003
376 MICTURITION DISORDER 1 0.0003
377 UNDERDOSE 21 0.0003
378 PETECHIAE 3 0.0003
379 PRODUCT ODOUR ABNORMAL 3 0.0003
380 DERMATITIS 6 0.0003
381 CARPAL TUNNEL SYNDROME 4 0.0003
382 RIGHT VENTRICULAR FAILURE 2 0.0003
383 SCRATCH 3 0.0003
384 HEART DISEASE CONGENITAL 1 0.0003
385 THERMAL BURN 2 0.0003
386 GLOSSITIS 1 0.0003
387 FIBRIN D DIMER INCREASED 1 0.0003
388 HAEMORRHAGIC DIATHESIS 1 0.0003
389 CONJUNCTIVAL HYPERAEMIA 1 0.0003
390 MONOCYTE COUNT INCREASED 1 0.0003
391 BLOOD PHOSPHORUS DECREASED 1 0.0003
392 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 8 0.0003
393 STAPHYLOCOCCAL INFECTION 9 0.0003
394 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 5 0.0003
395 MOUTH HAEMORRHAGE 2 0.0003
396 SENSITIVE SKIN 2 0.0003
397 HAEMATOMA 7 0.0003
398 ARTHROPOD BITE 2 0.0003
399 JOINT STIFFNESS 7 0.0003
400 MATERNAL EXPOSURE TIMING UNSPECIFIED 1 0.0003
401 STATUS EPILEPTICUS 3 0.0003
402 OSTEOPENIA 4 0.0003
403 DERMATITIS CONTACT 3 0.0003
404 INCREASED APPETITE 5 0.0003
405 BOWEL MOVEMENT IRREGULARITY 2 0.0003
406 CARDIOPULMONARY FAILURE 1 0.0003
407 CEREBRAL ATROPHY 1 0.0003
408 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
409 ASPHYXIA 2 0.0002
410 HYPERURICAEMIA 1 0.0002
411 FUNGAL INFECTION 8 0.0002
412 ABDOMINAL PAIN LOWER 6 0.0002
413 CONDITION AGGRAVATED 72 0.0002
414 HEPATIC CYTOLYSIS 3 0.0002
415 HAEMATURIA 8 0.0002
416 PYELONEPHRITIS 2 0.0002
417 SKIN SWELLING 2 0.0002
418 CHAPPED LIPS 1 0.0002
419 ORTHOSTATIC HYPOTENSION 4 0.0002
420 IMMOBILE 1 0.0002
421 MELANOCYTIC NAEVUS 1 0.0002
422 ASPARTATE AMINOTRANSFERASE INCREASED 12 0.0002
423 STEVENS-JOHNSON SYNDROME 5 0.0002
424 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
425 IMPAIRED GASTRIC EMPTYING 3 0.0002
426 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
427 LUMBAR VERTEBRAL FRACTURE 1 0.0002
428 IRON DEFICIENCY ANAEMIA 2 0.0002
429 LOCALISED OEDEMA 1 0.0002
430 FLANK PAIN 2 0.0002
431 ALANINE AMINOTRANSFERASE INCREASED 13 0.0002
432 BLOOD URINE PRESENT 4 0.0002
433 HYPERSENSITIVITY 39 0.0002
434 FEELING JITTERY 4 0.0002
435 GESTATIONAL DIABETES 1 0.0002
436 GASTROINTESTINAL TOXICITY 1 0.0002
437 HUMERUS FRACTURE 1 0.0002
438 HYPERTHYROIDISM 3 0.0002
439 FLUID OVERLOAD 3 0.0002
440 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
441 INFLAMMATORY BOWEL DISEASE 2 0.0002
442 CONSTIPATION 44 0.0002
443 INFLAMMATORY MARKER INCREASED 1 0.0002
444 ABDOMINAL TENDERNESS 1 0.0002
445 IMMUNODEFICIENCY 3 0.0002
446 INJECTION SITE INFLAMMATION 1 0.0002
447 HAEMORRHAGE INTRACRANIAL 3 0.0002
448 APPLICATION SITE SWELLING 1 0.0002
449 FLUID INTAKE REDUCED 1 0.0002
450 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
451 PERITONITIS BACTERIAL 2 0.0002
452 ECONOMIC PROBLEM 3 0.0002
453 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
454 SLUGGISHNESS 2 0.0002
455 CEREBRAL ISCHAEMIA 1 0.0002
456 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
457 DELUSION 3 0.0002
458 FAILURE TO THRIVE 1 0.0002
459 ACUTE MYELOID LEUKAEMIA 3 0.0002
460 MUCOSAL INFLAMMATION 5 0.0002
461 CATATONIA 1 0.0002
462 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
463 IRRITABLE BOWEL SYNDROME 4 0.0002
464 ANAL FISSURE 1 0.0002
465 HEREDITARY ANGIOEDEMA 2 0.0002
466 ABDOMINAL PAIN 43 0.0002
467 CHEILITIS 1 0.0002
468 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
469 METASTASES TO BONE 3 0.0002
470 MULTIPLE FRACTURES 3 0.0002
471 JAW DISORDER 1 0.0002
472 FAECALOMA 1 0.0002
473 ASTHENOPIA 1 0.0002
474 CHOKING SENSATION 1 0.0002
475 EXPIRED PRODUCT ADMINISTERED 6 0.0002
476 FOOT DEFORMITY 2 0.0002
477 FACE OEDEMA 3 0.0002
478 COLECTOMY 1 0.0002
479 MYOCARDIAL ISCHAEMIA 2 0.0002
480 GRANULOCYTOPENIA 1 0.0002
481 SCAB 2 0.0002
482 SCAR 3 0.0002
483 MICTURITION URGENCY 2 0.0002
484 HYPERTONIA 1 0.0002
485 MYOCARDITIS 2 0.0002
486 EXERCISE TOLERANCE DECREASED 1 0.0002
487 MOUTH SWELLING 1 0.0002
488 BLOOD URIC ACID INCREASED 1 0.0002
489 LOCAL SWELLING 3 0.0002
490 HYPOVOLAEMIA 1 0.0002
491 OSTEOPOROSIS 7 0.0002
492 ENERGY INCREASED 1 0.0002
493 BRADYKINESIA 1 0.0002
494 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
495 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 12 0.0002
496 GANGRENE 1 0.0002
497 APHASIA 5 0.0002
498 RENAL FAILURE ACUTE 7 0.0002
499 BURSITIS 2 0.0002
500 ADRENAL INSUFFICIENCY 2 0.0002
501 END STAGE RENAL DISEASE 3 0.0002
502 RESPIRATORY DEPRESSION 2 0.0002
503 ENCEPHALOPATHY 4 0.0002
504 CARDIOMEGALY 2 0.0002
505 LARYNGEAL OEDEMA 1 0.0002
506 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
507 CONJUNCTIVITIS 3 0.0002
508 GENERALISED OEDEMA 2 0.0002
509 PHARYNGITIS 2 0.0002
510 INFUSION SITE EXTRAVASATION 1 0.0002
511 URINARY TRACT INFECTION 27 0.0002
512 NEUROPATHY PERIPHERAL 15 0.0002
513 CYSTITIS 5 0.0002
514 PULMONARY FIBROSIS 3 0.0002
515 PRODUCT SUBSTITUTION ISSUE 9 0.0002
516 ENTERITIS 1 0.0002
517 ACUTE RESPIRATORY FAILURE 3 0.0002
518 ANGINA UNSTABLE 1 0.0002
519 HERPES SIMPLEX 1 0.0002
520 DEAFNESS 4 0.0002
521 DYSGRAPHIA 1 0.0002
522 ADVERSE REACTION 2 0.0002
523 MENINGITIS 1 0.0001
524 SWELLING 14 0.0001
525 CYTOKINE RELEASE SYNDROME 3 0.0001
526 BREAST MASS 1 0.0001
527 BONE MARROW FAILURE 3 0.0001
528 DISCOMFORT 9 0.0001
529 DRUG EXPOSURE DURING PREGNANCY 5 0.0001
530 CHRONIC KIDNEY DISEASE 11 0.0001
531 LYMPHOEDEMA 1 0.0001
532 INTERSTITIAL LUNG DISEASE 7 0.0001
533 INTENTIONAL DRUG MISUSE 3 0.0001
534 BLISTER 8 0.0001
535 DUODENAL ULCER 1 0.0001
536 OSTEOARTHRITIS 6 0.0001
537 SEASONAL ALLERGY 2 0.0001
538 DIVERTICULUM 1 0.0001
539 BRONCHOSPASM 2 0.0001
540 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
541 PRODUCT USE ISSUE 26 0.0001
542 SWELLING FACE 9 0.0001
543 DERMATITIS BULLOUS 1 0.0001
544 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
545 RESPIRATORY FAILURE 10 0.0001
546 GASTROENTERITIS 2 0.0001
547 MAJOR DEPRESSION 1 0.0001
548 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
549 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
550 RASH MACULO-PAPULAR 3 0.0001
551 EYE SWELLING 5 0.0001
552 PULMONARY MASS 2 0.0001
553 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
554 LIPASE INCREASED 1 0.0001
555 ATRIOVENTRICULAR BLOCK 1 0.0001
556 COGNITIVE DISORDER 6 0.0001
557 BONE DENSITY DECREASED 4 0.0001
558 GASTROINTESTINAL INFLAMMATION 1 0.0001
559 MULTIPLE ALLERGIES 1 0.0001
560 AFFECTIVE DISORDER 1 0.0001
561 PRODUCT USE COMPLAINT 2 0.0001
562 FURUNCLE 1 0.0001
563 BLOOD ALBUMIN DECREASED 1 0.0001
564 ULCER 2 0.0001
565 OBESITY 2 0.0001
566 SCIATICA 2 0.0001
567 PANCYTOPENIA 7 0.0001
568 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 6 0.0001
569 MIOSIS 1 0.0001
570 DYSKINESIA 5 0.0001
571 DECUBITUS ULCER 1 0.0001
572 LUNG DISORDER 6 0.0001
573 HICCUPS 1 0.0001
574 HAIR DISORDER 1 0.0001
575 DRY EYE 6 0.0001
576 PNEUMONIA ASPIRATION 3 0.0001
577 POLLAKIURIA 5 0.0001
578 HAEMODIALYSIS 1 0.0001
579 CELLULITIS 6 0.0001
580 INFUSION SITE ERYTHEMA 1 0.0001
581 CARDIAC OPERATION 1 0.0001
582 SKIN ULCER 3 0.0001
583 MULTI-ORGAN FAILURE 2 0.0001
584 HYSTERECTOMY 1 0.0001
585 EOSINOPHILIA 2 0.0001
586 BLOOD CALCIUM INCREASED 1 0.0001
587 GASTRITIS 3 0.0001
588 GRIP STRENGTH DECREASED 1 0.0001
589 LYMPHOCYTE COUNT DECREASED 2 0.0001
590 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
591 DRUG INEFFECTIVE 148 0.0001
592 MATERNAL EXPOSURE DURING PREGNANCY 10 0.0001
593 HAEMOLYTIC ANAEMIA 1 0.0001
594 HAEMARTHROSIS 1 0.0001
595 GASTROINTESTINAL INFECTION 1 0.0001
596 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
597 HEAVY MENSTRUAL BLEEDING 1 0.0001
598 LUPUS-LIKE SYNDROME 1 0.0001
599 PELVIC PAIN 2 0.0001
600 SKIN IRRITATION 5 0.0001
601 PRODUCT USE IN UNAPPROVED INDICATION 27 0.0001
602 INCREASED TENDENCY TO BRUISE 1 0.0001
603 HYPOKALAEMIA 5 0.0001
604 GRAND MAL CONVULSION 1 0.0001
605 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
606 GASTROINTESTINAL HAEMORRHAGE 9 0.0001
607 HAEMOPTYSIS 3 0.0001
608 HEPATIC STEATOSIS 2 0.0001
609 BACTERIAL INFECTION 2 0.0001
610 APPENDICITIS 1 0.0001
611 ERYTHEMA 22 0.0001
612 DEFORMITY 1 0.0001
613 OEDEMA PERIPHERAL 13 0.0001
614 LACERATION 1 0.0001
615 ABORTION INDUCED 1 0.0001
616 FOOT FRACTURE 2 0.0001
617 DYSPHAGIA 10 0.0001
618 COMA 5 0.0001
619 DIABETES MELLITUS 8 0.0001
620 RASH ERYTHEMATOUS 5 0.0001
621 HERPES ZOSTER 6 0.0001
622 DRUG PRESCRIBING ERROR 2 0.0001
623 DIZZINESS POSTURAL 1 0.0001
624 HEPATOMEGALY 1 0.0001
625 KNEE OPERATION 1 0.0001
626 URINARY INCONTINENCE 3 0.0001
627 HOSPICE CARE 1 0.0001
628 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
629 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
630 RENAL INJURY 3 0.0001
631 SINUS DISORDER 2 0.0001
632 HAEMATOCRIT DECREASED 2 0.0001
633 INABILITY TO AFFORD MEDICATION 1 0.0001
634 UPPER LIMB FRACTURE 2 0.0001
635 BRAIN INJURY 1 0.0001
636 HYPOTHERMIA 1 0.0001
637 EYELID PTOSIS 1 0.0001
638 NEUTROPHIL COUNT DECREASED 4 0.0001
639 MOTOR DYSFUNCTION 1 0.0001
640 BODY TEMPERATURE INCREASED 2 0.0001
641 ACUTE KIDNEY INJURY 15 0.0001
642 DRUG ADMINISTRATION ERROR 3 0.0001
643 HELICOBACTER INFECTION 1 0.0001
644 RIB FRACTURE 2 0.0001
645 EXPOSURE DURING PREGNANCY 6 0.0001
646 ROAD TRAFFIC ACCIDENT 4 0.0001
647 SPEECH DISORDER 5 0.0001
648 SEIZURE 11 0.0001
649 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
650 HALLUCINATION, VISUAL 2 0.0001
651 JOINT DISLOCATION 1 0.0001
652 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
653 WEIGHT DECREASED 26 0.0001
654 CONFUSIONAL STATE 15 0.0001
655 BALANCE DISORDER 8 0.0001
656 BIPOLAR DISORDER 1 0.0001
657 MENTAL DISORDER 4 0.0001
658 ASPIRATION 1 0.0001
659 BLOOD GLUCOSE FLUCTUATION 1 0.0001
660 EYE DISORDER 3 0.0001
661 MELAENA 2 0.0001
662 ANAPHYLACTIC REACTION 5 0.0001
663 FEBRILE NEUTROPENIA 6 0.0001
664 RENAL FAILURE 12 0.0001
665 BLOOD PRESSURE DECREASED 6 0.0001
666 SYNCOPE 9 0.0001
667 PULMONARY OEDEMA 4 0.0001
668 ANAEMIA 17 0.0001
669 INTESTINAL PERFORATION 1 0.0001
670 CHROMATURIA 2 0.0001
671 ASTHMA 10 0.0001
672 HEPATIC ENZYME INCREASED 6 0.0001
673 IMPAIRED DRIVING ABILITY 1 0.0001
674 ANXIETY 25 0.0001
675 PRODUCT AVAILABILITY ISSUE 2 0.0001
676 HAEMOGLOBIN DECREASED 9 0.0001
677 CARDIAC FAILURE 7 0.0001
678 SKIN DISCOLOURATION 4 0.0001
679 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
680 METASTASES TO LUNG 1 0.0001
681 PERICARDIAL EFFUSION 2 0.0001
682 DELIRIUM 3 0.0001
683 EYELID OEDEMA 1 0.0001
684 PRURITUS 33 0.0001
685 RENAL DISORDER 4 0.0001
686 CARDIAC DISORDER 8 0.0001
687 HYPOXIA 3 0.0001
688 OCULAR HYPERAEMIA 4 0.0001
689 ACCIDENT 1 0.0001
690 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
691 RENAL IMPAIRMENT 7 0.0001
692 DIABETIC KETOACIDOSIS 2 0.0001
693 CONTUSION 8 0.0001
694 CRYING 3 0.0001
695 HYPOGLYCAEMIA 4 0.0001
696 C-REACTIVE PROTEIN INCREASED 3 0.0001
697 STOMATITIS 5 0.0001
698 PRESYNCOPE 2 0.0001
699 ATRIAL FIBRILLATION 8 0.0001
700 RESTLESSNESS 3 0.0001
701 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
702 OSTEONECROSIS OF JAW 2 0.0001
703 ILEUS 1 0.0001
704 HEPATIC FUNCTION ABNORMAL 3 0.0001
705 CARDIOVASCULAR DISORDER 2 0.0001
706 HYPOPHAGIA 2 0.0001
707 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
708 ERECTILE DYSFUNCTION 2 0.0001
709 INFUSION SITE PAIN 1 0.0001
710 URTICARIA 13 0.0001
711 ANOREXIA 1 0.0001
712 HIATUS HERNIA 1 0.0001
713 INJECTION SITE INDURATION 1 0.0001
714 RESPIRATORY TRACT INFECTION 2 0.0001
715 SEDATION 2 0.0001
716 IMMUNE SYSTEM DISORDER 1 0.0001
717 ANKYLOSING SPONDYLITIS 1 0.0001
718 DYSMENORRHOEA 1 0.0001
719 EAR INFECTION 2 0.0001
720 EYE HAEMORRHAGE 1 0.0001
721 ABORTION SPONTANEOUS 3 0.0001
722 JOINT RANGE OF MOTION DECREASED 1 0.0001
723 EMOTIONAL DISTRESS 9 0.0001
724 DIZZINESS 37 0.0001
725 PULMONARY EMBOLISM 7 0.0001
726 PNEUMONITIS 2 0.0001
727 DRUG TOXICITY 1 0.0001
728 RASH 32 0.0001
729 GINGIVAL BLEEDING 1 0.0001
730 CORONARY ARTERY OCCLUSION 1 0.0001
731 MENTAL STATUS CHANGES 2 0.0001
732 COORDINATION ABNORMAL 1 0.0001
733 DEMENTIA 2 0.0001
734 WOUND 2 0.0001
735 OXYGEN SATURATION DECREASED 4 0.0001
736 BLOOD TEST ABNORMAL 1 0.0001
737 LYMPHOPENIA 1 0.0001
738 FLATULENCE 4 0.0001
739 DIALYSIS 1 0.0001
740 RED BLOOD CELL COUNT DECREASED 2 0.0001
741 RECTAL HAEMORRHAGE 3 0.0001
742 SKIN BURNING SENSATION 5 0.0001
743 CARDIOGENIC SHOCK 1 0.0001
744 DEVICE DISLOCATION 3 0.0001
745 SEPTIC SHOCK 3 0.0001
746 BACK PAIN 16 0.0001
747 APATHY 1 0.0001
748 OFF LABEL USE 60 0.0001
749 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001
750 LIVER DISORDER 3 0.0001
751 TACHYCARDIA 6 0.0001
752 DEHYDRATION 9 0.0001
753 RESPIRATORY DISORDER 2 0.0001
754 EPISTAXIS 5 0.0001
755 BONE LOSS 1 0.0001
756 HEPATIC FAILURE 2 0.0001
757 LACRIMATION INCREASED 2 0.0001
758 PLEURAL EFFUSION 4 0.0001
759 VERTIGO 4 0.0001
760 VISION BLURRED 9 0.0001
761 NEPHROLITHIASIS 3 0.0001
762 INSURANCE ISSUE 1 0.0001
763 EJECTION FRACTION DECREASED 1 0.0001
764 SWOLLEN TONGUE 2 0.0001
765 BRAIN FOG 1 0.0001
766 CYANOSIS 1 0.0001
767 ARTHRITIS 5 0.0001
768 PAIN 39 0.0001
769 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
770 HALLUCINATION, AUDITORY 1 0.0001
771 PRODUCTIVE COUGH 3 0.0001
772 ABSCESS 1 0.0001
773 THROMBOCYTOPENIA 7 0.0001
774 LOSS OF CONSCIOUSNESS 8 0.0001
775 MOVEMENT DISORDER 2 0.0001
776 INFECTION 9 0.0001
777 DYSPNOEA 35 0.0001
778 DRY MOUTH 5 0.0001
779 BLOOD POTASSIUM INCREASED 1 0.0001
780 DEPRESSION 14 0.0001
781 HYPERTENSION 13 0.0001
782 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 11 0.0001
783 IMPAIRED HEALING 2 0.0001
784 MANIA 1 0.0001
785 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
786 DRUG LEVEL INCREASED 1 0.0001
787 OVERDOSE 13 0.0001
788 LIP SWELLING 2 0.0001
789 SKIN DISORDER 2 0.0001
790 MUSCLE SPASMS 11 0.0001
791 URINARY RETENTION 2 0.0001
792 DRY SKIN 8 0.0001
793 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
794 SKIN EXFOLIATION 5 0.0001
795 PNEUMONIA 19 0.0001
796 METRORRHAGIA 1 0.0001
797 CHEST DISCOMFORT 6 0.0001
798 SINUSITIS 6 0.0001
799 FEELING ABNORMAL 14 0.0001
800 PYREXIA 20 0.0001
801 NIGHTMARE 2 0.0001
802 DEVICE DEFECTIVE 1 0.0001
803 GAIT DISTURBANCE 11 0.0001
804 HAEMORRHAGE 6 0.0001
805 HYPERKALAEMIA 2 0.0001
806 COVID-19 10 0.0001
807 HEART RATE DECREASED 2 0.0001
808 INJURY 4 0.0001
809 SLEEP DISORDER 4 0.0001
810 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
811 HEAD DISCOMFORT 1 0.0001
812 DRUG ERUPTION 1 0.0001
813 GALLBLADDER DISORDER 1 0.0001
814 CEREBRAL HAEMORRHAGE 2 0.0001
815 ADVERSE DRUG REACTION 5 0.0001
816 DISTURBANCE IN ATTENTION 3 0.0001
817 GASTROENTERITIS VIRAL 1 0.0001
818 ACCIDENTAL OVERDOSE 2 0.0001
819 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
820 SOMNOLENCE 11 0.0001
821 AGITATION 4 0.0001
822 PAIN IN EXTREMITY 16 0.0001
823 INFLUENZA 6 0.0001
824 HYPONATRAEMIA 3 0.0001
825 BLOOD SODIUM DECREASED 1 0.0001
826 ARTHRALGIA 22 0.0001
827 UNEVALUABLE EVENT 4 0.0001
828 HYPOCALCAEMIA 1 0.0001
829 MUSCULAR WEAKNESS 6 0.0001
830 COLITIS 2 0.0001
831 GASTRIC ULCER 1 0.0001
832 CONVULSION 3 0.0001
833 PERIPHERAL SWELLING 8 0.0001
834 GLAUCOMA 1 0.0001
835 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
836 DRUG INTOLERANCE 5 0.0001
837 HERNIA 1 0.0001
838 DYSTONIA 1 0.0001
839 HAEMORRHOIDS 1 0.0001
840 CHILLS 6 0.0001
841 SURGERY 3 0.0001
842 KIDNEY INFECTION 1 0.0001
843 ALOPECIA 10 0.0001
844 HEART RATE INCREASED 5 0.0001
845 BLOOD PRESSURE ABNORMAL 1 0.0001
846 CARDIAC FAILURE CONGESTIVE 4 0.0000
847 ILL-DEFINED DISORDER 3 0.0000
848 FEEDING DISORDER 1 0.0000
849 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
850 INJECTION SITE WARMTH 1 0.0000
851 ILLNESS 5 0.0000
852 TREATMENT FAILURE 4 0.0000
853 MALAISE 21 0.0000
854 CEREBROVASCULAR ACCIDENT 8 0.0000
855 EATING DISORDER 1 0.0000
856 PLATELET COUNT DECREASED 5 0.0000
857 IMPAIRED WORK ABILITY 1 0.0000
858 DIARRHOEA 30 0.0000
859 HYPOACUSIS 2 0.0000
860 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
861 AMNESIA 3 0.0000
862 BLOOD PRESSURE INCREASED 7 0.0000
863 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
864 HOSPITALISATION 7 0.0000
865 INFUSION RELATED REACTION 3 0.0000
866 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
867 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 9 0.0000
868 HEART RATE IRREGULAR 1 0.0000
869 RHEUMATOID ARTHRITIS 5 0.0000
870 SUICIDAL IDEATION 4 0.0000
871 MEMORY IMPAIRMENT 6 0.0000
872 TINNITUS 2 0.0000
873 ADVERSE EVENT 4 0.0000
874 CHEST PAIN 8 0.0000
875 ARRHYTHMIA 2 0.0000
876 TREMOR 7 0.0000
877 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
878 MIGRAINE 4 0.0000
879 BLOOD PRESSURE FLUCTUATION 1 0.0000
880 LOCALISED INFECTION 1 0.0000
881 INSOMNIA 11 0.0000
882 MENTAL IMPAIRMENT 1 0.0000
883 CEREBRAL INFARCTION 1 0.0000
884 PRODUCT DOSE OMISSION ISSUE 12 0.0000
885 ABASIA 1 0.0000
886 LEUKOPENIA 2 0.0000
887 HALLUCINATION 3 0.0000
888 FLUID RETENTION 2 0.0000
889 COUGH 11 0.0000
890 HEPATITIS 1 0.0000
891 DRUG RESISTANCE 1 0.0000
892 ABDOMINAL PAIN UPPER 8 0.0000
893 ANAPHYLACTIC SHOCK 1 0.0000
894 ABDOMINAL DISTENSION 4 0.0000
895 ECZEMA 2 0.0000
896 BREAST CANCER FEMALE 1 0.0000
897 JAUNDICE 1 0.0000
898 BLOOD BILIRUBIN INCREASED 1 0.0000
899 RASH PRURITIC 2 0.0000
900 OEDEMA 2 0.0000
901 NEUTROPENIA 5 0.0000
902 TREATMENT NONCOMPLIANCE 2 0.0000
903 ABNORMAL DREAMS 1 0.0000
904 ARTHROPATHY 2 0.0000
905 MEDICATION ERROR 2 0.0000
906 FEELING COLD 1 0.0000
907 ABDOMINAL DISCOMFORT 6 0.0000
908 INTENTIONAL DOSE OMISSION 1 0.0000
909 ANGINA PECTORIS 1 0.0000
910 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
911 LIVER FUNCTION TEST ABNORMAL 1 0.0000
912 DYSSTASIA 1 0.0000
913 PALPITATIONS 4 0.0000
914 BONE PAIN 2 0.0000
915 LABORATORY TEST ABNORMAL 1 0.0000
916 CATARACT 2 0.0000
917 GASTROINTESTINAL DISORDER 3 0.0000
918 HYPOAESTHESIA 5 0.0000
919 BLOOD POTASSIUM DECREASED 1 0.0000
920 NO ADVERSE EVENT 6 0.0000
921 FALL 11 0.0000
922 FEELING HOT 2 0.0000
923 INJECTION SITE RASH 1 0.0000
924 GYNAECOMASTIA 1 0.0000
925 FEMUR FRACTURE 1 0.0000
926 VISUAL IMPAIRMENT 4 0.0000
927 ASTHENIA 12 0.0000
928 HEADACHE 20 0.0000
929 WEIGHT INCREASED 7 0.0000
930 DECREASED APPETITE 7 0.0000
931 NEOPLASM MALIGNANT 2 0.0000
932 GAIT INABILITY 1 0.0000
933 VOMITING 14 0.0000
934 EYE PRURITUS 1 0.0000
935 GASTRIC DISORDER 1 0.0000
936 NAUSEA 23 0.0000
937 LYMPHADENOPATHY 1 0.0000
938 THERAPY INTERRUPTED 2 0.0000
939 HYPERGLYCAEMIA 1 0.0000
940 INJECTION SITE MASS 1 0.0000
941 DYSGEUSIA 2 0.0000
942 DYSARTHRIA 1 0.0000
943 INJECTION SITE SWELLING 2 0.0000
944 DEATH 22 0.0000
945 ABNORMAL BEHAVIOUR 1 0.0000
946 DISORIENTATION 1 0.0000
947 HYPOTENSION 5 0.0000
948 THROMBOSIS 2 0.0000
949 FATIGUE 19 0.0000
950 LUNG NEOPLASM MALIGNANT 1 0.0000
951 INFLUENZA LIKE ILLNESS 2 0.0000
952 INJECTION SITE ERYTHEMA 3 0.0000
953 COMPLETED SUICIDE 2 0.0000
954 CARDIO-RESPIRATORY ARREST 1 0.0000
955 MYALGIA 4 0.0000
956 DEVICE LEAKAGE 1 0.0000
957 INTENTIONAL PRODUCT MISUSE 2 0.0000
958 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
959 ANGIOEDEMA 1 0.0000
960 COLITIS ULCERATIVE 1 0.0000
961 DEVICE ISSUE 2 0.0000
962 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
963 NASOPHARYNGITIS 4 0.0000
964 OROPHARYNGEAL PAIN 2 0.0000
965 BREAST CANCER 2 0.0000
966 BLOOD GLUCOSE DECREASED 1 0.0000
967 DYSPEPSIA 2 0.0000
968 AGGRESSION 1 0.0000
969 FLUSHING 2 0.0000
970 INFLAMMATION 1 0.0000
971 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
972 DERMATITIS ATOPIC 1 0.0000
973 DRUG DEPENDENCE 3 0.0000
974 DRUG EFFECT DECREASED 1 0.0000
975 DRUG DOSE OMISSION 3 0.0000
976 HAEMATOCHEZIA 1 0.0000
977 TOXICITY TO VARIOUS AGENTS 3 0.0000
978 EYE PAIN 1 0.0000
979 INCORRECT DOSE ADMINISTERED 4 0.0000
980 LETHARGY 1 0.0000
981 EYE IRRITATION 1 0.0000
982 DISEASE PROGRESSION 2 0.0000
983 IRRITABILITY 1 0.0000
984 JOINT SWELLING 2 0.0000
985 INJECTION SITE PAIN 5 0.0000
986 DEEP VEIN THROMBOSIS 1 0.0000
987 PRODUCT QUALITY ISSUE 2 0.0000
988 MOBILITY DECREASED 1 0.0000
989 BRONCHITIS 1 0.0000
990 HOT FLUSH 1 0.0000
991 ACNE 1 0.0000
992 CARDIAC ARREST 1 0.0000
993 HYPERHIDROSIS 1 0.0000
994 BLOOD GLUCOSE INCREASED 1 0.0000